Tus Pharmaceutical Group Co Ltd (000590) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tus Pharmaceutical Group Co Ltd (000590) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.24 Million ≈ $327.43K USD) by net assets (CN¥585.85 Million ≈ $85.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 000590 market cap overview for the company's overall valuation and market capitalisation.
Tus Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Tus Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tus Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tus Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore Tus Pharmaceutical Group Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Groenlandsbanken AS
CO:GRLA
|
0.003x |
|
LiveWire Group Inc.
NYSE:LVWR
|
-0.459x |
|
CapMan Oyj B
HE:CAPMAN
|
0.066x |
|
Hoasen Group
VN:HSG
|
0.138x |
|
KC Co. Ltd
KO:029460
|
0.008x |
|
Hangzhou Todaytec Digital Co Ltd Class A
SHE:300743
|
0.067x |
|
Crowell Development Corp
TW:2528
|
0.083x |
|
Aju IB Investment Co. Ltd
KQ:027360
|
0.013x |
Annual Cash Flow Conversion Efficiency for Tus Pharmaceutical Group Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Tus Pharmaceutical Group Co Ltd from 1998 to 2025. View 000590 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥549.49 Million ≈ $80.41 Million |
CN¥28.96 Million ≈ $4.24 Million |
0.053x | +82.22% |
| 2024-12-31 | CN¥601.23 Million ≈ $87.98 Million |
CN¥17.39 Million ≈ $2.54 Million |
0.029x | +174.17% |
| 2023-12-31 | CN¥728.20 Million ≈ $106.56 Million |
CN¥-28.39 Million ≈ $-4.16 Million |
-0.039x | -150.29% |
| 2022-12-31 | CN¥702.49 Million ≈ $102.80 Million |
CN¥54.47 Million ≈ $7.97 Million |
0.078x | +109.99% |
| 2021-12-31 | CN¥682.32 Million ≈ $99.85 Million |
CN¥25.20 Million ≈ $3.69 Million |
0.037x | -53.74% |
| 2020-12-31 | CN¥644.88 Million ≈ $94.37 Million |
CN¥51.48 Million ≈ $7.53 Million |
0.080x | +70.04% |
| 2019-12-31 | CN¥622.16 Million ≈ $91.04 Million |
CN¥29.21 Million ≈ $4.27 Million |
0.047x | +4059.95% |
| 2018-12-31 | CN¥579.72 Million ≈ $84.83 Million |
CN¥654.24K ≈ $95.74K |
0.001x | +100.74% |
| 2017-12-31 | CN¥583.33 Million ≈ $85.36 Million |
CN¥-89.14 Million ≈ $-13.04 Million |
-0.153x | -24.06% |
| 2016-12-31 | CN¥263.96 Million ≈ $38.63 Million |
CN¥-32.51 Million ≈ $-4.76 Million |
-0.123x | +58.14% |
| 2015-12-31 | CN¥205.79 Million ≈ $30.11 Million |
CN¥-60.56 Million ≈ $-8.86 Million |
-0.294x | -6.42% |
| 2014-12-31 | CN¥184.11 Million ≈ $26.94 Million |
CN¥-50.91 Million ≈ $-7.45 Million |
-0.277x | -1907.88% |
| 2013-12-31 | CN¥269.51 Million ≈ $39.44 Million |
CN¥4.12 Million ≈ $603.20K |
0.015x | -62.93% |
| 2012-12-31 | CN¥478.58 Million ≈ $70.03 Million |
CN¥19.75 Million ≈ $2.89 Million |
0.041x | -53.10% |
| 2011-12-31 | CN¥350.83 Million ≈ $51.34 Million |
CN¥30.87 Million ≈ $4.52 Million |
0.088x | -71.13% |
| 2010-12-31 | CN¥278.88 Million ≈ $40.81 Million |
CN¥84.98 Million ≈ $12.43 Million |
0.305x | +106.35% |
| 2009-12-31 | CN¥231.22 Million ≈ $33.84 Million |
CN¥34.14 Million ≈ $5.00 Million |
0.148x | +36.63% |
| 2008-12-31 | CN¥322.78 Million ≈ $47.23 Million |
CN¥34.89 Million ≈ $5.10 Million |
0.108x | -51.20% |
| 2007-12-31 | CN¥307.22 Million ≈ $44.96 Million |
CN¥68.04 Million ≈ $9.96 Million |
0.221x | +357.48% |
| 2006-12-31 | CN¥271.26 Million ≈ $39.69 Million |
CN¥-23.33 Million ≈ $-3.41 Million |
-0.086x | -141.28% |
| 2005-12-31 | CN¥268.54 Million ≈ $39.30 Million |
CN¥55.96 Million ≈ $8.19 Million |
0.208x | +15.06% |
| 2004-12-31 | CN¥267.57 Million ≈ $39.15 Million |
CN¥48.46 Million ≈ $7.09 Million |
0.181x | +292.13% |
| 2003-12-31 | CN¥259.16 Million ≈ $37.92 Million |
CN¥-24.43 Million ≈ $-3.57 Million |
-0.094x | -128.08% |
| 2002-12-31 | CN¥280.91 Million ≈ $41.11 Million |
CN¥94.30 Million ≈ $13.80 Million |
0.336x | +283.41% |
| 2001-12-31 | CN¥278.65 Million ≈ $40.78 Million |
CN¥-51.00 Million ≈ $-7.46 Million |
-0.183x | -944.87% |
| 2000-12-31 | CN¥380.02 Million ≈ $55.61 Million |
CN¥8.23 Million ≈ $1.20 Million |
0.022x | +172.82% |
| 1999-12-31 | CN¥347.80 Million ≈ $50.89 Million |
CN¥-10.35 Million ≈ $-1.51 Million |
-0.030x | -305.60% |
| 1998-12-31 | CN¥268.78 Million ≈ $39.33 Million |
CN¥3.89 Million ≈ $569.06K |
0.014x | -- |
About Tus Pharmaceutical Group Co Ltd
Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offer… Read more